Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX1KEK
|
||||
Drug Name |
4-(3-Bromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-piperazine-1-carboxylic acid 1-oxy-pyridin-3-yl ester
|
||||
Synonyms |
CHEMBL352727
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C24H22BrClN4O3
|
||||
Canonical SMILES |
[O-][n+]1cccc(OC(=O)N2CCN(CC2)C3c4ccc(Cl)cc4CCc5cc(Br)cnc35)c1
|
||||
InChI |
InChI=1S/C24H22BrClN4O3/c25-18-12-17-4-3-16-13-19(26)5-6-21(16)23(22(17)27-14-18)28-8-10-29(11-9-28)24(31)33-20-2-1-7-30(32)15-20/h1-2,5-7,12-15,23H,3-4,8-11H2
|
||||
InChIKey |
PZDLWSGRQNLKCH-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.